Abstract
The advent of DNA microarray technology has provided a means to identify changes in the expression of thousands of genes simultaneously. This research tool has enabled investigators to study the effects of adrenergic receptor (AR) stimulation on gene expression on a large scale and has led to the identification of many genes that are regulated by adrenergic receptors (ARs). Microarrays have been used to compare the effects of α1A-AR, α1B-AR, and α1D-AR stimulation on gene expression. This work demonstrated that all three α1-AR subtypes commonly regulate many types of genes. However, genes that are regulated by only one or two α1-AR subtypes have also been identified. These data provide evidence that the physiological roles of the three α1-AR subtypes are not redundant despite their activation by the same ligand, use of common signal transduction pathways, and overlapping tissue distributions. Microarray studies have also identified genes that underlie AR-mediated regulation of the cell cycle, apoptosis, neuronal differentiation, cell hypertrophy, and other biological processes that are regulated by ARs. In addition, microarrays have identified changes in gene expression that accompany AR-mediated disease states, including cardiac hypertrophy, neurodegeneration, and hypermetabolism. The purpose of this chapter is to review how microarrays have contributed to our understanding of AR function at the genomic level.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lee EJ, Lee SH, Jung JW, et al. Differential regulation of cAMP-mediated gene transcription and ligand selectivity by MC3R and MC4R melanocortin receptors. Eur J Biochem 2001;268:582–591.
Carvalho CR, Carvalheira JB, Lima MH, et al. Novel signal transduction pathways for luteinizing hormone and interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3 kinase/Akt pathways. Endocrinology 2003;144:638–647.
Naor Z, Benard O, Seger R. Activation of MAPK cascades by G-protein-coupled receptors: the case of gonadotropin-releasing hormone receptor. Trends Endocrinol Metab 2000;11:91–99.
Akiyama M, Minami Y, Kuriyama K, Shibata S. MAP kinase-dependent induction of clock gene expression by α1-adrenergic receptor activation. FEBS Lett 2003;542:109–114.
Zhong H, Lee D, Robeva A, Minneman KP. Signaling pathways activated by α1-adrenergic receptor subtypes in PC12 cells. Life Sci 2001;68:2269–2276.
Tittelbach V, Volff JN, Giray J, Ratge D, Wisser H. Agonist-induced down-regulation of the β2-adrenoceptor and its mRNA in human mononuclear leukocytes. Biochem Pharmacol 1998;56:967–975.
Taniguchi M, Miura K, Iwao H, Yamanaka S. Quantitative assessment of DNA microarrays-comparison with Northern blot analyses. Genomics 2001;71:34–39.
Gonzalez-Cabrera PJ, Gaivin RJ, Yun J, et al. Genetic profiling of α1-adrenergic receptor subtypes by oligonucleotide microarrays: coupling to interleukin-6 secretion but differences in STAT3 phosphorylation and gp-130. Mol Pharmacol 2003;63:1104–1116.
Ten Hagen KG, Balys MM, Tabak LA, Melvin JE. Analysis of isoproterenol-induced changes in parotid gland gene expression. Physiol Genomics 2002;8:107–114.
Yun J, Zuscik MJ, Gonzalez-Cabrera P, et al. Gene expression profiling of α1B-adrenergic receptor-induced cardiac hypertrophy by oligonucleotide arrays. Cardiovasc Res 2003;57:443–455.
Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complimentary DNA microarray. Science 1995;270:467–470.
Zhong H, Minneman KP. Activation of tyrosine kinases by α1A-adrenergic and growth factor receptors in transfected PC12 cells. Biochem J 1999;344:889–894.
Minneman KP, Lee D, Zhong H, Berts A, Abbott KL, Murphy TJ. Transcriptional responses to growth factor and G protein-coupled receptors in PC12 cells: comparison of α1-adrenergic receptor subtypes. J Neurochem 2000;74:2392–2400.
Garcia-Sainz JA, Alcantara-Hernandez R, Vazquez-Prado J. α1-Adrenoceptor subtype activation increases proto-oncogene mRNA levels. Role of protein kinase C. Eur J Pharmacol 1998;342:311–317.
Iwaki K, Sukhatme VP, Shubeita HE, Chien KR. α-and β-adrenergic stimulation induces distinct patterns of immediate early gene expression in neonatal rat myocardial cells. fos/jun expression is associated with sarcomere assembly; Egr-1 induction is primarily an α1-mediated response. J Biol Chem 1990;265:13,809–13,817.
Zuscik MJ, Sands S, Ross SA, et al. Overexpression of the α1B-adrenergic receptor causes apoptotic neurodegeneration: multiple system atrophy. Nat Med 2000;6:1388–1394.
Theroux TL, Esbenshade TA, Peavy RD, Minneman KP. Coupling efficiencies of human alpha 1-adrenergic receptor subtypes: titration of receptor density and responsiveness with inducible and repressible expression vectors. Mol Pharmacol 1996;50:1376–1387.
Erami C, Zhang H, Ho JG, French DM, Faber JE. α1-Adrenoceptor stimulation directly induces growth of vascular wall in vivo. Am J Physiol 2002;283:H1577–H1587.
Hu ZW, Shi XY, Lin RZ, Chen J, Hoffman BB. α1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase. J Pharmacol Exp Ther 1999;290:28–37.
Marinese D, Patel R, Walden PD. Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in mice. Prostate 2003;54:230–237.
Refsnes M, Thoresen GH, Sandnes D, Dajani OF, Dajani L, Christoffers T. Stimulatory and inhibitory effects of catecholamines on DNA synthesis in primary rat hepatocyte cultures: role of α1-and β-adrenergic mechanisms. J Cell Physiol 1992;151:164–171.
Pabbathi VK, Brennan H, Muzworthy A, et al. Catecholaminergic regulation of proliferation and survival in rat forebrain paraventricular germinal cells. Brain Res 1997;760:22–33.
Auer KL, Spector MS, Tombes RM, et al. α-Adrenergic inhibition of proliferation in HEPG2 cells stably transfected with the α1B-adrenergic receptor through a p42MAPkinase/p21Cip1/WAF1-dependent pathway. FEBS Lett 1998;436:131–138.
Gonzalez-Cabrera PJ, Ting S, Yun J, McCune DF, Rorabaugh BR, Perez DM. Differential Regulation of the cell cycle by α1-adrenergic receptor subtypes. Endocrinology 2004;145:5157–5167.
Shibata K, Katsuma S, Koshimizu T, et al. α1-Adrenergic receptor subtypes differentially control the cell cycle of transfected CHO cells through a cAMP-dependent mechanism involving p27Kip1. J Biol Chem 2003;278:672–678.
Milano CA, Dolber PC, Rockman HA, et al. Myocardial expression of a constitutively active α1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci USA 1994;91:10,109–10,113.
Lin F, Owens WA, Chen S, et al. Targeted α1A-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy. Circ Res 2001;89:343–350.
Cavalli A, Lattion AL, Hummler E, et al. Decreased blood pressure response in mice deficient of the α1B-adrenergic receptor. Proc Natl Acad Sci USA 1997;94:11,589–11,594.
Rokosh DG, Simpson PC. Knockout of the α1a/c-adrenergic receptor subtype: The α1a/c is expressed in resistance arteries and is required to maintain arterial blood pressure. Proc Natl Acad Sci USA 2002;99:9474–9479.
Tanoue A, Nasa Y, Koshimizu T, et al. The α1D-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. J Clin Invest 2002;109:765–775.
Perez DM, Hwa J, Gaivin R, Mathur M, Brown F, Graham RM. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol 1996;49:112–122.
Hwa J, Gaivin RJ, Porter JE, Perez DM. Synergism of constitutive activity in α1-adrenergic receptor activation. Biochemistry 1997;36:633–639.
Zuscik MJ, Chalothorn D, Hellard D, et al. Hypotension, autonomic failure, and cardiac hypertrophy in transgenic mice overexpressing the α1B-adrenergic receptor. J Biol Chem 2001;276:13,738–13,743.
Kunieda T, Zuscik MJ, Boongird A, Perez DM, Lüders HO, Najm IM. Systemic overexpression of the α1B-adrenergic receptor in mice: an animal model of epilepsy. Epilepsia 2002;43:1324–1329.
Papay R, Zuscik MT, Ross SA, et al. Mice expressing the α1b-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation. J Neurochem 2002;83:1–12.
Yun J, Gaivin RJ, McCune DF, et al. Gene expression profile of neurodegeneration induced by α1B-adrenergic receptor overactivity: NMDA/GABAA dysregulation and apoptosis. Brain 2003;126:2667–2681.
Eguchi S, Inagami T. Signal transduction of angiotensin II type I receptor through receptor tyrosine kinase. Regul Pept 2000;91:13–20.
Maudsley S, Pierce KL, Zamah AM, et al. The β2 adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly for a multireceptor complex with epidermal growth factor. J Biol Chem 2000;275:9572–9580.
Kuppuswamy D, Kerr C, Narishige T, Kasi VS, Menick DR, Cooper G 4th. Association of tyrosine-phosphorylated c-Src with the cytoskeleton of hypertrophying myocardium. J Biol Chem 1997;272:4500–4508.
Fuller SJ, Gillespie-Brown J, Sugden PH. Oncogenic src, raf and ras stimulate a hypertrophic pattern of gene expression and increase cell size in neonatal rat ventricular myocytes. J Biol Chem 1998;273:18,146–18,152.
Daaka Y, Luttrell LM, Lefkowitz RJ. Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997;390:88–91.
Tayebati SK, Bronzetti E, Morra Di Cella S, et al. In situ hybridization and immunocytochemistry of α1-adrenoceptors in human peripheral blood lymphocytes. J Auton Pharmacol 2000;20:305–312.
Devaux B, Scholz D, Hirche A, Klovekorn WP, Schaper J. Upregulation of cell adhesion molecules and the presence of low grade inflammation in human chronic heart failure. Eur Heart J 1997;18:470–479.
Warraich RS, Dunn MJ, Yacoub MH. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: proinflammatory antibodies in DCM patients. Biochem Biophys Res Commun 1999;259:255–261.
Caforio ALP, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail 2002;4:411–417.
Lefkos N, Boura P, Boudonas G, et al. Immunopathogenic mechanisms in hypertension. Am J Hypertens 1995;8:1141–1145.
Wahnschaffe U, Ebert U, Löscher W. The effects of lesions of the posterior piriform cortex on amygdala kindling in the rat. Brain Res 1993;615:295–303.
Scanziani M, Gähwiler BH, Thompson SM. Presynaptic inhibition of excitatory synaptic transmission mediated by α adrenergic receptors in area CA3 of the rat hippocampus in vitro. J Neurosci 1993;13:5393–5401.
Murphy TV, Majewski H. Modulation of noradrenaline release in slices of rat kidney cortex through α1-and α2-adrenoceptors. Eur J Pharmacol 1989;169:285–295.
Laifenfeld D, Klein E, Ben-Shachar D. Norepinephrine alters the expression of genes involved in neuronal sprouting and differentiation: relevance for major depression and antidepressant mechanisms. J Neurochem 2002;83:1054–1064.
Taraviras S, Olli-Lahdesmaki T, Lymperopoulos A, et al. Subtype-specific neuronal differentiation of PC12 cells transfected with α2-adrenergic receptors. Eur J Cell Biol 2002;81:363–374.
Rowe SJ, messenger NJ, Warner AE. The role of noradrenaline in the differentiation of amphibian embryonic neurons. Development 1993;119:1343–1357.
Kazmi SM, Mishra RK. Identification of α2-adrenergic receptor sites in human retinoblastoma (Y-79) and neuroblastoma (SH-SY5Y) cells. Biochem Biophys Res Commun 1989;158:921–928.
Crossin KL, Krushel LA. Cellular signaling by neural cell adhesion molecules of the immunoglobulin family. Dev Dyn 2000;21:8260–8279.
Timpl R, Brown JC. The laminins. Matrix Biol 1994;14:13,729–13,732.
Meiri KF, Saffell JL, Walsh FS, Doherty P. Neurite outgrowth stimulated by neural cell adhesion molecules requires growth-associated protein-43 (GAP-43) function and is associated with GAP-43 phosphorylation in growth cones. J Neurosci 1998;18:10,429–10,437.
Drigues N, Polytyrev T, Bejar C, Weinstock M, Youdim MBH. cDNA gene expression profile of rat hippocampus after chronic treatment with antidepressant drugs. J Neural Transm 2003;110:1413–1436.
Elkstrom J. Autonomic control of salivary secretion. Proc Finn Dent Soc 1989;85:323–331.
Brenner GM, Wulf RG. Adrenergic β receptors mediating submandibular salivary gland hypertrophy in the rat. J Pharmacol Exp Ther 1981;218:608–612.
Barroso I, Benito B, Barci-Jimenez C, Hernandez A, Obregon MJ, Santisteban P. Norepinephrine, tri-iodothyronine, and insulin upregulate glyceraldehydes-3-phosphate dehydrogenase mRNA during brown adipocyte differentiation. Eur J Endocrinol 1999;141:169–179.
Chance WT, Nelson JL, Foley-Nelson T, Kim MW, Fischer JE. The relationship of burn-induced hypermetabolism to central and peripheral catecholamines. J Trauma 1989;29:306–312.
Wilmore DW, Long JM, Mason AD, Skreen RW, Pruitt BA. Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg 1974;180:653–669
Herndon DN, Dasu HRK, Wolfe RR, Barrow RE. Gene expression profiles and protein balance in skeletal muscle of burned children after β-adrenergic blockade. Am J Physiol Endocrinol Metab 2003;285:E783–E789.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Rorabaugh, B., Yun, J., Perez, D.M. (2006). Microarray Analysis of Novel Adrenergic Receptor Functions. In: Perez, D.M. (eds) The Adrenergic Receptors. The Receptors. Humana Press. https://doi.org/10.1385/1-59259-931-1:365
Download citation
DOI: https://doi.org/10.1385/1-59259-931-1:365
Publisher Name: Humana Press
Print ISBN: 978-1-58829-423-4
Online ISBN: 978-1-59259-931-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)